Request for Public Comment: 60 Day Notice for Extension of Fast Track Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery: IHS Customer Service Satisfaction and Similar Surveys, 54462-54464 [2021-21350]
Download as PDF
<![CDATA[
54462
Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices
Diana Espinosa,
Acting Administrator.
[FR Doc. 2021–21241 Filed 9–30–21; 8:45 am]
BILLING CODE 4165–15–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Indigenous Innovation and
Health Equity Tribal Advisory
Committee; Solicitation of
Nominations for Delegates
Office of Minority Health,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice of solicitation of
nominations for delegates for the Center
for Indigenous Innovation and Health
Equity Tribal Advisory Committee.
AGENCY:
The U.S. Department of
Health and Human Services (HHS)
Office of Minority Health (OMH) hereby
gives notice that OMH is establishing a
Center for Indigenous Innovation and
Health Equity Tribal Advisory
Committee (CIIHE TAC) and accepting
nominations of qualified candidates to
serve as primary and alternate delegates
for the CIIHE TAC, in alignment with
the 12 geographic areas served by the
Indian Health Service (IHS).
DATES: Nomination letters for the CIIHE
TAC must be sent to the address noted
below no later than 6:00 p.m. EST on
October 29, 2021.
ADDRESSES: All nominations should be
emailed to: Violet Woo, Designated
Federal Officer for the CIIHE TAC, at
Violet.Woo@hhs.gov. Please use the
subject line ‘‘OMH CIIHE Tribal
Advisory Committee’’.
FOR FURTHER INFORMATION CONTACT: For
information and guidance about the
nomination process for CIIHE TAC
delegates, please contact Violet Woo,
Designated Federal Officer at
Violet.Woo@hhs.gov. CIIHE TAC
nomination guidance and sample
nomination letters also are available on
the OMH website’s Tribal Leader Letters
section: https://
www.minorityhealth.hhs.gov/omh/
browse.aspx?lvl=3&lvlid=62#triballeader-letters.
SUPPLEMENTARY INFORMATION:
Authorized under Section 1707 of the
Public Health Service Act, 42 U.S.C.
300u–6, as amended, the mission of
OMH is to improve the health of racial
and ethnic minority populations
through the development of health
policies and programs that help
eliminate health disparities. OMH
awards and other activities are intended
to support the identification of effective
policies, programs, and practices for
SUMMARY:
VerDate Sep<11>2014
18:04 Sep 30, 2021
Jkt 256001
improving health outcomes and to
promote the sustainability and
dissemination of these approaches.
Under the authority of Public Law
116–260 (2021 Consolidated
Appropriations Act), Congress directed
OMH to create a CIIHE to support
research, education, service, and policy
development advancing Indigenous
solutions that ultimately address health
disparities in American Indian/Alaska
Native (AI/AN) and Native Hawaiian
and Pacific Islander (NHPI) populations.
OMH is establishing the CIIHE TAC to
ensure that Tribal Leaders have
meaningful and timely input in the
development of the priorities and
activities established to address the
focus areas of the CIIHE. The CIIHE TAC
shall support, but not supplant,
government-to-government consultation
activities that OMH undertakes.
TAC Membership: The CIIHE TAC
will consist of 16 delegate positions:
One from each of the 12 geographic
areas served by the Indian Health
Service and four National At-Large
Member positions.
Alaska Area
Albuquerque Area
Bemidji Area
Billings Area
California Area
Great Plains Area
Nashville Area
Navajo Area
Oklahoma Area
Phoenix Area
Portland Area
Tucson Area
National At-Large Members (4)
OMH recommends a two (2) year term
length for each delegate, but delegates’
term length will be established by the
TAC’s charter.
Eligibility: The CIIHE TAC delegates
must be: (1) Elected tribal officials from
a federally recognized tribe acting in
their official capacity as elected officials
of their tribe, with authority to act on
behalf of the tribe; or (2) individuals
designated by an elected tribal official.
Designees must have the authority to act
on behalf of the tribal official and the
tribe and be qualified to represent the
views of the AI/AN tribes in the area
from which they are nominated. No
delegate of the CIIHE TAC may be an
employee of the federal government.
Nomination Procedures: CIIHE TAC
candidates must be nominated by an
elected tribal leader. The nomination
letter must be on tribal letterhead and
signed by an elected tribal leader, and
must include the following information:
• Name of the nominee
• Nominee’s official title
• Name of the nominee’s tribe
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
• Date of nominee’s election to official
tribal position and term length
• Nominee’s contact information
(mailing address, phone, and email)
• Nominee’s expertise that is relevant to
the CIIHE TAC
• Name of tribal leader submitting the
nomination
• Official title of tribal leader
submitting the nomination
• Contact information for tribal leader
submitting the nomination and/or
administrative office for tribal
government
CIIHE TAC nomination guidance and
sample nomination letters are available
on the OMH website’s Tribal Leader
Letters section: https://
www.minorityhealth.hhs.gov/omh/
browse.aspx?lvl=3&lvlid=62#triballeader-letters.
Selection Process: OMH is responsible
for selecting and finalizing CIIHE TAC
members.
Eligible nominees will be considered
in the following priority order:
1. Tribal President/Chairperson/
Governor
2. Tribal Vice-President/ViceChairperson/Lt. Governor
3. Elected or Appointed Tribal Official
4. Designated Tribal Official with
authority to act on behalf of Tribal
leader
In the event that there is more than
one nomination for a given IHS area,
OMH will make a determination of
representation based on submitted
nomination materials.
Nominees will be notified of the
status of delegate selection in November
2021.
Dated: September 24, 2021.
Violet Woo,
Designated Federal Officer, Center for
Indigenous Innovation and Health Equity
Tribal Advisory Committee.
[FR Doc. 2021–21253 Filed 9–30–21; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60 Day
Notice for Extension of Fast Track
Generic Clearance for the Collection of
Qualitative Feedback on Agency
Service Delivery: IHS Customer
Service Satisfaction and Similar
Surveys
Indian Health Service, HHS.
Notice and request for
comments. Request for extension of
approval.
AGENCY:
ACTION:
E:\FR\FM\01OCN1.SGM
01OCN1
Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices
In compliance with the
Paperwork Reduction Act of 1995, the
Indian Health Service (IHS) invites the
general public to take this opportunity
to comment on the information
collection Office of Management and
Budget (OMB) Control Number 0917–
0036, ‘‘Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery.’’ This notice
announces our intent to submit this
previously approved information
collection, which expires January 31,
2022, to OMB for approval of an
extension and solicit comments on
specific aspects for the proposed
information collection.
DATES: Consideration will be given to all
comments received by November 30,
2021.
For Comments: Submit comments to
Evonne Bennett by Email at
Evonne.Bennett@ihs.gov.
Comments submitted in response to
this notice will be made available to the
public by publishing them in the 30 day
Federal Register notice for this
information collection. For this reason,
please do not include information of a
confidential nature, such as sensitive
personal information or proprietary
information. If comments are submitted
via email, the email address will be
automatically captured and included as
part of the comment that is placed in the
public docket and made available on the
internet. Please note that responses to
this public comment request containing
any routine notice about the
confidentiality of the communication
will be treated as public comments that
may be made available to the public
notwithstanding the inclusion of the
routine notice.
A copy of the draft supporting
statement is available at
www.regulations.gov (see Docket ID
[IHS_FRDOC_0001].
SUPPLEMENTARY INFORMATION: The IHS is
submitting the proposed information
collection to OMB for review, as
required by the Paperwork Reduction
Act of 1995, as amended, and its
implementing regulations. This notice is
soliciting comments from members of
the public and affected agencies as
required by 44 U.S.C. 3506(c)(2)(A) and
5 CFR 1320.8(d) concerning the
proposed collection of information to:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information; (3) Enhance the quality,
SUMMARY:
VerDate Sep<11>2014
18:04 Sep 30, 2021
Jkt 256001
utility, and clarity of the information to
be collected; and (4) Minimize the
burden of the collection of information
on those who are to respond; including
through the use of appropriate
automated collection techniques of
other forms of information technology,
e.g., permitting electronic submission of
responses.
Title: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery: IHS Customer
Service Satisfaction and Similar
Surveys.
Type of Information Collection
Request: Three year extension approval
of this information collection.
OMB Control Number: 0917–0036.
Abstract: The proposed information
collection activity provides a means to
garner qualitative customer and
stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. Qualitative
feedback is information that provides
useful insights on perceptions and
opinions, but is not statistical surveys
that yield quantitative results that can
be generalized to the population of
study. This feedback will provide
insights into customer or stakeholder
perceptions, experiences and
expectations, provide an early warning
of issues with service, or focus attention
on areas where communication, training
or changes in operations might improve
delivery of products or services. These
collections will allow for ongoing,
collaborative and actionable
communications between the Agency
and its customers and stakeholders. It
will also allow feedback to contribute
directly to the improvement of program
management.
The solicitation of feedback will target
areas such as: Timeliness,
appropriateness, accuracy of
information, courtesy, efficiency of
service delivery, and resolution of
issues with service delivery. Responses
will be assessed to plan and inform
efforts to improve or maintain the
quality of service offered to the public.
If this information is not collected, vital
feedback from customers and
stakeholders on the agency’s services
will be unavailable.
The agency will only submit a
collection for approval under this
generic clearance if it meets the
following conditions:
• Information gathered will be used
only internally for general service
improvement and program management
purposes and is not intended for release
outside of the agency;
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
54463
• Information gathered will not be
used for the purpose of substantially
informing influential policy decisions;
• Information gathered will yield
qualitative information; the collections
will not be designed or expected to
yield statistically reliable results or used
as though the results are generalizable to
the population of study;
• The collections are voluntary;
• The collections are low-burden for
respondents (based on considerations of
total burden hours, total number of
respondents, or burden-hours per
respondent) and are low-cost for both
the respondents and the Federal
Government;
• The collections are noncontroversial and do not raise issues of
concern to other Federal agencies;
• Any collection is targeted to the
solicitation of opinions from
respondents who have experience with
the program or may have experience
with the program in the near future; and
• With the exception of information
needed to provide remuneration for
participants of focus groups and
cognitive laboratory studies, personally
identifiable information (PII) is
collected only to the extent necessary
and is not retained.
Feedback collected under this generic
clearance provides useful information,
but it does not yield data that can be
generalized to the overall population.
This type of generic clearance for
qualitative information will not be used
for quantitative information collections
that are designed to yield reliably
actionable results, such as monitoring
trends over time or documenting
program performance. Such data uses
require more rigorous designs that
address: The target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
As a general matter, information
collections will not result in any new
system of records containing privacy
information and will not ask questions
of a sensitive nature, such as sexual
behavior and attitudes, religious beliefs,
and other matters that are commonly
considered private.
E:\FR\FM\01OCN1.SGM
01OCN1
54464
Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices
Current Actions: Extension of
approval for a collection of information.
Type of Review: Extension.
Affected Public: Individuals and
households, businesses and
organizations, and Tribal governments.
Estimated Number of Respondents:
105,000.
Below are projected annual average
estimates for the next three years:
Average Expected Annual Number of
activities: 100.
Average number of Respondents per
Activity: 1,050.
Annual responses: 105,000.
Frequency of Response: Once per
request.
Average minutes per response: 10.
Burden hours: 17,500.
There are no direct costs to
respondents to report.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.
Comment Due Date: Your comments
regarding this information collection are
best assured of having full effect if
received within 30 days of the date of
this publication.
Elizabeth A. Fowler,
Acting Director, Indian Health Service.
[FR Doc. 2021–21350 Filed 9–30–21; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: NIDCR Special Grants
Review Committee.
Date: October 28–29, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:04 Sep 30, 2021
Jkt 256001
Place: National Institutes of Health, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Nisan Bhattacharyya,
Ph.D., Scientific Review Officer, Scientific
Review Branch, NIDCR, NIH, 6701
Democracy Boulevard, Suite 668, Bethesda,
MD 20892, 301–451–2405,
nisan.bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: September 28, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–21380 Filed 9–30–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; OD–21–005:
Short Courses on Innovative Methodologies
and Approaches in the Behavioral and Social
Sciences.
Date: October 25, 2021.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
Bethesda, MD 20892, (301) 443–7193,
hargravesl@mail.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Genetics
of Health and Disease Study Section.
Date: November 1–2, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christopher Payne, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 2208,
Bethesda, MD 20892, 301–402–3702,
christopher.payne@nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Biostatistical Methods and Research Design
Study Section.
Date: November 2–3, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victoriya Volkova,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3140,
Bethesda, MD 20892, (301) 594–7781,
victoriya.volkova@nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Oral, Dental and Craniofacial Sciences Study
Section.
Date: November 4–5, 2021.
Time: 9:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yi-Hsin Liu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, (301) 435–
1781, liuyh@csr.nih.gov.
Name of Committee: Applied Immunology
and Disease Control Integrated Review
Group; Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: November 4–5, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Daum, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
Bethesda, MD 20892, 301–827–7233,
susan.boyle-vavra@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Infectious Disease and Immunology B.
Date: November 4–5, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Uma Basavanna, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–1398, uma.basavanna@
nih.gov.
E:\FR\FM\01OCN1.SGM
01OCN1
]]>Agencies
[Federal Register Volume 86, Number 188 (Friday, October 1, 2021)]
[Notices]
[Pages 54462-54464]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21350]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60 Day Notice for Extension of Fast
Track Generic Clearance for the Collection of Qualitative Feedback on
Agency Service Delivery: IHS Customer Service Satisfaction and Similar
Surveys
AGENCY: Indian Health Service, HHS.
ACTION: Notice and request for comments. Request for extension of
approval.
-----------------------------------------------------------------------
[[Page 54463]]
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
Indian Health Service (IHS) invites the general public to take this
opportunity to comment on the information collection Office of
Management and Budget (OMB) Control Number 0917-0036, ``Generic
Clearance for the Collection of Qualitative Feedback on Agency Service
Delivery.'' This notice announces our intent to submit this previously
approved information collection, which expires January 31, 2022, to OMB
for approval of an extension and solicit comments on specific aspects
for the proposed information collection.
DATES: Consideration will be given to all comments received by November
30, 2021.
For Comments: Submit comments to Evonne Bennett by Email at
[email protected].
Comments submitted in response to this notice will be made
available to the public by publishing them in the 30 day Federal
Register notice for this information collection. For this reason,
please do not include information of a confidential nature, such as
sensitive personal information or proprietary information. If comments
are submitted via email, the email address will be automatically
captured and included as part of the comment that is placed in the
public docket and made available on the internet. Please note that
responses to this public comment request containing any routine notice
about the confidentiality of the communication will be treated as
public comments that may be made available to the public
notwithstanding the inclusion of the routine notice.
A copy of the draft supporting statement is available at
www.regulations.gov (see Docket ID [IHS_FRDOC_0001].
SUPPLEMENTARY INFORMATION: The IHS is submitting the proposed
information collection to OMB for review, as required by the Paperwork
Reduction Act of 1995, as amended, and its implementing regulations.
This notice is soliciting comments from members of the public and
affected agencies as required by 44 U.S.C. 3506(c)(2)(A) and 5 CFR
1320.8(d) concerning the proposed collection of information to: (1)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (2) Evaluate the
accuracy of the agency's estimate of the burden of the proposed
collection of information; (3) Enhance the quality, utility, and
clarity of the information to be collected; and (4) Minimize the burden
of the collection of information on those who are to respond; including
through the use of appropriate automated collection techniques of other
forms of information technology, e.g., permitting electronic submission
of responses.
Title: Generic Clearance for the Collection of Qualitative Feedback
on Agency Service Delivery: IHS Customer Service Satisfaction and
Similar Surveys.
Type of Information Collection Request: Three year extension
approval of this information collection.
OMB Control Number: 0917-0036.
Abstract: The proposed information collection activity provides a
means to garner qualitative customer and stakeholder feedback in an
efficient, timely manner, in accordance with the Administration's
commitment to improving service delivery. Qualitative feedback is
information that provides useful insights on perceptions and opinions,
but is not statistical surveys that yield quantitative results that can
be generalized to the population of study. This feedback will provide
insights into customer or stakeholder perceptions, experiences and
expectations, provide an early warning of issues with service, or focus
attention on areas where communication, training or changes in
operations might improve delivery of products or services. These
collections will allow for ongoing, collaborative and actionable
communications between the Agency and its customers and stakeholders.
It will also allow feedback to contribute directly to the improvement
of program management.
The solicitation of feedback will target areas such as: Timeliness,
appropriateness, accuracy of information, courtesy, efficiency of
service delivery, and resolution of issues with service delivery.
Responses will be assessed to plan and inform efforts to improve or
maintain the quality of service offered to the public. If this
information is not collected, vital feedback from customers and
stakeholders on the agency's services will be unavailable.
The agency will only submit a collection for approval under this
generic clearance if it meets the following conditions:
Information gathered will be used only internally for
general service improvement and program management purposes and is not
intended for release outside of the agency;
Information gathered will not be used for the purpose of
substantially informing influential policy decisions;
Information gathered will yield qualitative information;
the collections will not be designed or expected to yield statistically
reliable results or used as though the results are generalizable to the
population of study;
The collections are voluntary;
The collections are low-burden for respondents (based on
considerations of total burden hours, total number of respondents, or
burden-hours per respondent) and are low-cost for both the respondents
and the Federal Government;
The collections are non-controversial and do not raise
issues of concern to other Federal agencies;
Any collection is targeted to the solicitation of opinions
from respondents who have experience with the program or may have
experience with the program in the near future; and
With the exception of information needed to provide
remuneration for participants of focus groups and cognitive laboratory
studies, personally identifiable information (PII) is collected only to
the extent necessary and is not retained.
Feedback collected under this generic clearance provides useful
information, but it does not yield data that can be generalized to the
overall population. This type of generic clearance for qualitative
information will not be used for quantitative information collections
that are designed to yield reliably actionable results, such as
monitoring trends over time or documenting program performance. Such
data uses require more rigorous designs that address: The target
population to which generalizations will be made, the sampling frame,
the sample design (including stratification and clustering), the
precision requirements or power calculations that justify the proposed
sample size, the expected response rate, methods for assessing
potential non-response bias, the protocols for data collection, and any
testing procedures that were or will be undertaken prior to fielding
the study. Depending on the degree of influence the results are likely
to have, such collections may still be eligible for submission for
other generic mechanisms that are designed to yield quantitative
results.
As a general matter, information collections will not result in any
new system of records containing privacy information and will not ask
questions of a sensitive nature, such as sexual behavior and attitudes,
religious beliefs, and other matters that are commonly considered
private.
[[Page 54464]]
Current Actions: Extension of approval for a collection of
information.
Type of Review: Extension.
Affected Public: Individuals and households, businesses and
organizations, and Tribal governments.
Estimated Number of Respondents: 105,000.
Below are projected annual average estimates for the next three
years:
Average Expected Annual Number of activities: 100.
Average number of Respondents per Activity: 1,050.
Annual responses: 105,000.
Frequency of Response: Once per request.
Average minutes per response: 10.
Burden hours: 17,500.
There are no direct costs to respondents to report.
An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid OMB control number.
Comment Due Date: Your comments regarding this information
collection are best assured of having full effect if received within 30
days of the date of this publication.
Elizabeth A. Fowler,
Acting Director, Indian Health Service.
[FR Doc. 2021-21350 Filed 9-30-21; 8:45 am]
BILLING CODE 4165-16-P
